IVIg therapy in PANDAS: Analysis of the current literature. David S. Younger et al. J Neurol Neurosurg 2016; 3(3):125
An analysis of clinical series of children with PANDAS confirmed the beneficial response to IVIg consistent with its role as immune modulatory therapy. Its use in PANDAS early in the course of the disease was generally safe and without serious side-effects.